Administration of L-thyroxine does not improve the response of the hypothalamo-pituitary-ovarian axis to clomiphene citrate in functional hypothalamic amenorrhea
V. De Leo et al., Administration of L-thyroxine does not improve the response of the hypothalamo-pituitary-ovarian axis to clomiphene citrate in functional hypothalamic amenorrhea, EUR J OB GY, 90(1), 2000, pp. 103-108
Citations number
25
Categorie Soggetti
Reproductive Medicine
Journal title
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY
Objective: To investigate the hypothalamo-pituitary-ovarian axis in women w
ith functional hypothalamic amenorrhea to determine whether the combination
of L-thyroxine and clomiphene citrate produces a qualitative and quantitat
ive increase in induced ovulatory cycles. Setting: Gynecological Endocrinol
ogy Research Center, University of Siena (Italy). Patients: 16 young women
with functional hypothalamic amenorrhea and 15 women with normal cycles in
early follicular phase. Design: Administration of 50 mu g GnRH and 200 mu g
TRH. The women with functional hypothalamic amenorrhea were divided into g
roups A (n = 8) and B (n = 8). Both groups were given 100 mg/day clomiphene
for 5 days/month for 3 months. Women in group A were also given 75 mcg/day
thyroid hormone (L-thyroxine) for 3 months. Main outcome measures: Compari
son of basal and stimulated levels of gonadotropins, TSH and Prl, in groups
A and B. Qualitative and quantitative comparison of ovulatory cycles induc
ed in the groups. Results: Administration of clomiphene and clomiphene plus
L-thyroxine was evaluated in the second and third months of treatment and
was followed by a total of 11 ovulatory cycles, six in group A and five in
group B. No significant difference was found between groups. Mean progester
one concentrations measured 16 days after the last clomiphene tablet were 5
.5+/-1.2 ng/ml in group A and 5.1+/-1.3 ngl/ml in group B. Conclusions: Adm
inistration of L-thyroxine with clomiphene does not improve the response of
the hypothalamo-pituitary-ovarian axis to clomiphene citrate or the number
of ovulatory cycles and does not reduce luteal phase defects. (C) 2000 Els
evier Science ireland Ltd. All rights reserved.